Latest Social Impact News

Metals Australia Ltd reports key milestones in its Lac Carheil Graphite Project, achieving battery-grade spherical graphite purity and selecting Sept-Îles as the preferred site for its Battery Anode Material plant.

Jumbo Interactive has inked a five-year SaaS agreement to power RSL Queensland’s Dream Home Art Union lottery, Australia’s largest prize home lottery. This deal marks a strategic shift from reseller to platform partner, reinforcing Jumbo’s leadership in the charity lottery sector.

Euro Manganese Inc. reports significant progress on its Chvaletice Project and Bécancour Plant, positioning itself as a key Western supplier of high-purity manganese critical for EV batteries. The company highlights strong feasibility results, strategic financing partnerships, and multiple offtake agreements amid an expected global supply deficit.

Eclipse Metals has secured a crucial renewal of its Greenland exploration licence, extending its tenure to 2027 and clearing the way toward a mining licence for its rare earth project in a geopolitically strategic region.

Patriot Battery Metals has reached a significant milestone in the permitting process for its Shaakichiuwaanaan Lithium Project, with federal and provincial environmental assessments now aligned and progressing on schedule.

PolyNovo Limited stands to benefit from proposed U.S. Medicare changes that introduce a flat reimbursement rate for outpatient wound care skin substitutes, potentially reshaping the competitive landscape in favour of cost-effective, clinically proven products.

Canyon Resources’ Definitive Feasibility Study confirms Minim Martap as a major bauxite project with a 33% ore reserve increase and robust economics, targeting production start in early 2026.

Anson Resources has submitted a permit application for a production-scale disposal well at its Green River Lithium Project, marking a key step toward full-scale lithium production in Utah. This well will support both demonstration and future operations, enhancing geological understanding and resource modeling.

Hearts and Minds Investments Limited (HM1) reported a stellar FY25 with total comprehensive income soaring to $124.8 million, nearly doubling the prior year, alongside a dividend increase and sustained philanthropic commitments.

Mesoblast Limited has reported its FY2025 results, highlighting the FDA approval and US commercial launch of Ryoncil, its first mesenchymal stromal cell therapy, alongside a $102.1 million net loss and $161.6 million in cash reserves.

McMillan Shakespeare Limited reported steady FY25 growth with Normalised UNPATA of $103.2 million and an 8.3% dividend yield, underpinned by digital innovation and strategic investments.

Future Generation Global Limited has reported a 20.8% increase in its investment portfolio over the past year, prompting a boost in its fully franked interim dividend to 4.0 cents per share. This performance outpaces global market averages and underscores the company's sustainable investment approach.